CASI Pharmaceuticals (CASIF) Gross Margin (2022 - 2025)
CASI Pharmaceuticals (CASIF) recorded Gross Margin of 51.14% in Q4 2025, up 26.97 percentage points from 24.17% a year earlier and up 28.18 percentage points from the prior quarter.
CASI Pharmaceuticals (CASIF) Gross Margin (2022 - 2025) Analysis & Trends
For FY2025, CASI Pharmaceuticals reported Gross Margin of 48.65%, up 9.59 percentage points from FY2024.
- Annual Gross Margin has a five-year change of +11.44 percentage points (FY2020 to FY2025).
- Across earlier years, Gross Margin came in at 39.06% in FY2024 (-20.13 pp), 59.19% in FY2023 (-4.10 pp), 63.28% in FY2022 (+4.91 pp) and 58.38% in FY2021 (+21.17 pp).
- Quarterly Gross Margin has ranged from 22.96% in Q3 2025 to 72.00% in Q4 2022 over the past five years.
- On a year-over-year basis, Gross Margin rose in two of the last eight quarters, with an average year-over-year change of -6.92 percentage points.
- Peak year-over-year performance for Gross Margin in the last five years was a gain of 26.97 percentage points in Q4 2025, against a drop of 34.88 percentage points in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at 22.96% (Q3 2025), 49.29% (Q2 2025) and 58.00% (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | CASI Pharmaceuticals | 2.67 Mn | -18.15 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 51.14% |
| Sep 30, 2025 | 22.96% |
| Jun 30, 2025 | 49.29% |
| Mar 31, 2025 | 58.00% |
| Dec 31, 2024 | 24.17% |
| Sep 30, 2024 | 51.91% |
| Jun 30, 2024 | 51.95% |
| Mar 31, 2024 | 52.98% |
| Dec 31, 2023 | 59.05% |
| Sep 30, 2023 | 58.72% |
| Jun 30, 2023 | 59.41% |
| Mar 31, 2023 | 59.53% |
| Dec 31, 2022 | 72.00% |
| Sep 30, 2022 | 58.42% |
| Jun 30, 2022 | 58.59% |
| Mar 31, 2022 | 58.53% |
CASI Pharmaceuticals Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=CASIF&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "CASIF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=CASIF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();